Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic
Shilo Lefresne(BC Cancer Agency), Eric Berthelet(University of British Columbia), W. Jiang(Surrey Memorial Hospital), Karen Levy(Cornell University), Paula Kostuik(BC Cancer Agency), Michael McKenzie(Provincial Health Services Authority), Robert Olson(BC Cancer Agency), Rosemary Cashman(BC Cancer Agency), Ann Hulstyn(BC Cancer Agency), Jonn Wu, Mitchell Liu
Cited by 12
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2016|736
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532